Gilead Sciences reported $67.98B in Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acorda Therapeutics ACOR:US $ 491.5M 92.55M
Agios Pharmaceuticals AGIO:US $ 1874.6M 613.83M
Alexion Pharmaceuticals ALXN:US $ 18650.2M 547.2M
ALKERMES ALKS:US $ 1937.57M 59.35M
Alnylam Pharmaceuticals ALNY:US $ 3509.43M 254.16M
Amgen AMGN:US $ 59773M 2766M
Arena Pharmaceuticals ARNA:US $ 1084.66M 99.28M
Biogen BIIB:US $ 24470.4M 615.7M
Biomarin Pharmaceutical BMRN:US $ 5898.5M 93.44M
Bluebird Bio BLUE:US $ 1454.46M 182.82M
Bristol Myers Squibb BMY:US $ 110797M 1638M
Coherus Biosciences CHRS:US $ 739.54M 46.24M
Eli Lilly And LLY:US $ 47809M 970.7M
Gilead Sciences GILD:US $ 67984M 492M
GlaxoSmithKline GSK:LN 77011M 1068M
Glaxosmithkline GSK:US $ 77011M 1068M
Intercept Pharmaceuticals ICPT:US $ 523.22M 3.11M
Moderna Inc MRNA:US 16.15B 3.46B
Neurocrine Biosciences NBIX:US $ 1956.4M 110M
Novartis NOVN:VX SF 124015M 2263M
Ptc Therapeutics PTCT:US $ 2058.67M 53.27M
Puma Biotechnology PBYI:US $ 260M 1.34M
Regeneron Pharmaceuticals REGN:US $ 21485.9M 3713.7M
Sangamo Biosciences SGMO:US $ 835.36M 41.73M
Sarepta Therapeutics SRPT:US $ 2759.07M 6.16M
Teva Pharmaceutical Industries TEVA:US $ 49195M 191M
United Therapeutics UTHR:US $ 4844.9M 203.9M
Vertex Pharmaceuticals VRTX:US $ 12221.69M 106.63M
YTE INCY:US $ 3904.62M 243.19M